INNATE PHARMA EUR0.05 earnings per share and revenue

0EVI earnings per share for the last semiannual are -0.12 EUR whereas the estimation was -0.40 EUR which accounts for 70.25% surprise. Företagets omsättning för samma period uppgår till 21.42 M EUR trots den uppskattade siffran 16.82 M EUR. Estimated earnings per share for the next semiannual are -0.33 EUR, and revenue is expected to reach 10.27 M EUR. Also watch annual changes over time to get a bigger picture of 0EVI earnings per share and revenue dynamics.